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Rasch Analysis of the Health Assessment 
Questionnaire Disability Index in Psoriatic Arthritis 
The cross-cultural validity of the Health Assessment Questionnaire Disability Index 
(HAQ-DI) in psoriatic arthritis (PSA) has not been well studied. 
Objective 
To assess the validity of the HAQ-DI in PSA and determine its invariance to different 
patient characteristics including culture.  
Patients 
We included patients diagnosed with PsA recruited into GRACE project,1 carried out 
over 15 countries in Europe, N America, S America and Asia. The HAQ-DI data from 
baseline visit was used, including: age, gender, disease duration, disease type and 
the degree of skin involvement 
Analysis 
We undertook Rasch analysis2 to determine the ƐĐĂůĞ ?Ɛ validity, person separation 
index (PSI) reliability, unidimensionality, targeting and the invariance of the scale 
across patient subgroups based on culture, age, gender, disease duration, disease 
type and extent of skin involvement.    
 
Given fit to the model and unidimensionality, we calibrated an interval-level scale 
to enable transformation of raw HAQ-DI scores into Rasch-transformed values 
which can be used in parametric analyses (given a normal distribution and 
adequate sample sizes) alongside other outcome measures.  
In Europe and N America, HAQ-DI is a cross-
culturally valid and reliable measure of disability 
in PsA. Rasch-transformed values can be used 
with confidence alongside other outcome 
measures in parametric analyses.  
Conclusion 
Results 
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Region Model Fit ^ŵŝƚŚ ?ƐdĞƐƚ3 
N  ʖ ?ŝŶƚĞƌĂĐƚŝŽŶ ?Ɖ ? PSI Independent  
t-tests (95%CI) 
UK 66 8.575 (0.379) 0.885 0.047 (0.001 to 0.094) 
N America 83 5.299 (0.725) 0.860 0.015 (-0.022 to 0.052) 
Europe (non-UK) 132 25.356 (0.064) 0.855 0.036 (0.003 to 0.070) 
S America 45 6.086 (0.638) 0.765 0.051 (0.003 to 0.100) 
Asia 27 8.027 (0.431) 0.818 0.029 (-0.044 to 0.101) 
Perfect model fit P-value > 0.05 >0.7 Lower bound 95%CI <0.05 
Item Fit Statistics 
The Rasch-transformed values need to be divided by 8 to get a total HAQ 
score which ranges from 0 to 3. 
Thresholds ordering Summary measures of model fit 
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 The HAQ-DI was invariant to all subgroups of patients in the N America 
dataset 
 In the pooled dataset, the HAQ-DI displayed differential item functioning 
(DIF) by type of arthritis, where those with oligoarthritis were more likely 
to have lower scores on the dressing & grooming item than those with 
polyarthritis.  
Leeds Institute of Rheumatic and Musculoskeletal Medicine 
HAQ-DI 1 
HAQ-DI 2 
HAQ-DI 3 
HAQ-DI 4 
HAQ-DI 5 
HAQ-DI 6 
HAQ-DI 7 
HAQ-DI 8 
Item Loc SE Fit Res X2 P 
HAQ-DI 1 0.227 0.087 -0.960 13.204 0.067 
HAQ-DI 2 0.118 0.087 -0.165 8.080 0.326 
HAQ-DI 3 0.236 0.084 2.339 7.320 0.396 
HAQ-DI 4 0.826 0.087 0.250 12.825 0.076 
HAQ-DI 5 -0.287 0.077 -0.816 10.203 0.177 
HAQ-DI 6 -0.552 0.080 -2.154 11.425 0.121 
HAQ-DI 7 -0.066 0.080 1.780 8.985 0.254 
HAQ-DI 8 -0.503 0.081 -0.878 4.267 0.749 
PSI = Patient Separation Index Reliability (internal consistency equivalent to ŚƌŽŶďĂĐŚ ?Ɛ alpha) 
Asia includes Australia, Korea and New Zealand 
The sample sizes in S America and Asia were too small to reliably determine model fit  Loc = location  SE = Standard error  
Fit Res = Standardised fit residuals Non-significant p-value for X2= fit to the model 
Invariance 
Total of 503 patients with PsA (diagnosed by a physician) 
 Male = 287, female = 217 
 Mean age = 50.8 years, SD = 13.1  
 Psoriatic arthritis duration, mean = 9.8 years, SD = 9.9 
 Psoriasis duration, mean = 18.4 years, SD = 13.7 
Patient characteristics 
Raw 
score 
Person location 
(on logit scale) 
Rasch-transformed 
values  
0 -4.558 0.0 
1 -3.699 2.1 
2 -3.080 3.6 
3 -2.635 4.7 
4 -2.275 5.6 
5 -1.963 6.4 
6 -1.680 7.0 
7 -1.415 7.7 
8 -1.160 8.3 
9 -0.909 8.9 
10 -0.658 9.5 
11 -0.406 10.2 
12 -0.151 10.8 
13 0.109 11.4 
14 0.376 12.1 
15 0.652 12.8 
16 0.943 13.5 
17 1.253 14.2 
18 1.587 15.0 
19 1.953 15.9 
20 2.361 16.9 
21 2.831 18.1 
22 3.404 19.5 
23 4.184 21.4 
24 5.246 24.0 
Interval-level scale calibration 
Targeting 
This study was funded by Pfizer 
Patients with 
severe disability 
are well targeted 
by HAQ-DI items 
Patients with severe 
disability and polyarthritis 
are well targeted by the 
HAQ-DI items 
